XGX Pharma ApS: Financial statements 2014
CVR: 32289290
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
XGX Pharma ApS (CVR 32289290) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -14,436 compared with DKK 144,707 the year before. Equity in the 2014 report amounted to DKK -144,865.
- Profit/Loss
- DKK -14,436
- Equity
- DKK -144,865
- Total Assets
- DKK 466,272
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -14 t. | -145 t. | - |
| 2013 | - | 145 t. | 145 t. | 130 t. | - |
| 2012 | - | 84 t. | 96 t. | -14 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
XGX Pharma ApS has published its annual report for 2013. Gross profit came to DKK 144,613, and the net result was DKK 144,707.
About XGX Pharma ApS
XGX Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens-Nikolaj Schøier. The board consists of Per Anders Larnholt (chair) and Johan Frödin. The company is owned by Unimedic Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 32,338,381 and a net result of DKK 16,074,119 compared with DKK 4,453,433 the year before. Equity in the 2025 report amounted to DKK 30,787,180.